Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Janet Franklin, MD, MPH
Children's Hospital Los Angeles
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
228 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sydney Children'S Hospital
Randwick, New South Wales, Australia
- Children'S Hospital at Westmead
Westmead, New South Wales, Australia
- Royal Children'S Hospital
Brisbane, Queensland, Australia
- Women'S and Children'S Hospital
North Adelaide, South Australia, Australia
- Royal Children'S Hospital
Parkville, Victoria, Australia
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- Alberta Children'S Hospital
Calgary, Alberta, Canada
- Cross Cancer Institute at University of Alberta
Edmonton, Alberta, Canada
- Children'S & Women'S Hospital of British Columbia
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Janeway Children'S Health and Rehabilitation Centre
St. John's, Newfoundland and Labrador, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Mcmaster Children'S Hospital at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Children'S Hospital of Western Ontario
London, Ontario, Canada
- Children'S Hospital of Eastern Ontario
Ottawa, Ontario, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Hopital Sainte Justine
Montreal, Quebec, Canada
- Montreal Children'S Hospital at Mcgill University Health Center
Montreal, Quebec, Canada
- Centre de Recherche Du Centre Hospitalier de L'Universite Laval
Sainte-Foy, Quebec, Canada
- Allan Blair Cancer Centre at Pasqua Hospital
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre at the University of Saskatchewan
Saskatoon, Saskatchewan, Canada
- University Medical Center Groningen
Groningen, Netherlands
- Starship Children'S Health
Auckland, New Zealand
- Puerto Rico Cancer Center at University of Puerto Rico - Medical Sciences Campus
San Juan, Puerto Rico
- San Jorge Children'S Hospital
Santurce, Puerto Rico
- Swiss Pediatric Oncology Group Bern
Bern, Switzerland
- Swiss Pediatric Oncology Group Geneva
Geneva, Switzerland
- Swiss Pediatric Oncology Group Lausanne
Lausanne, Switzerland
- Comprehensive Cancer Center at University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of South Alabama Cancer Research Institute
Mobile, Alabama, United States
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Southern California Permanente Medical Group
Downey, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Rebecca and John Moores Ucsd Cancer Center
La Jolla, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center
Loma Linda, California, United States
- Jonathan Jaques Children'S Cancer Center at Miller Children'S Hospital
Long Beach, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center at Ucla
Los Angeles, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2002
- Primary completion
- 31 Mar 2006
- Completion
- 30 Sept 2006
- Last update posted
- 8 Aug 2014
- Registered enrollment
- 12
- Registry id
- NCT00021242
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.